The NHS already uses a number of genomic tests to identify possible gene changes that can cause health conditions or disorders.³

However, a driving force to increase the use of genomics and pharmacogenomics is the National Genomic Medicine Service for England (GMS). This is part of a programme “to create the most advanced genomic healthcare system in the world”, with work in three core areas: diagnosis and personalised medicines, prevention, and research.⁴

To support the NHS Long Term Plan, the aims of the GMS include:⁵

• being first national health care system to offer whole genome sequencing as part of routine care
• sequencing 500,000 whole genomes by 2023/24 and help transform healthcare for maximum patient benefit, including for all children with cancer or children who are seriously ill with a likely genetic disorder
• extending access to molecular diagnostics and offering genomic testing routinely to all people with cancer
• linking and correlating genomic data to help provide new treatments and diagnostic approaches, while helping patients make informed decisions about their care.

Hospital pharmacies were alerted to the implications of the GMS in 2020. NHS England has been encouraging pharmacy team members to learn about genomics and personalised medicine via: https://www.genomicseducation.hee.nhs.uk/.⁶